AbstractObjectivesThis study examined the effectiveness of Korean medical treatment for two patients complaining of discomfort after receiving Pfizer COVID-19 vaccine.
MethodsThe patients were hospitalized for 50 days and 12 days, respectively. They were treated with herbal medicine, acupuncture, electroacupuncture, and moxibustion. We used the Numerical Rating Scale (NRS) on numbness in extremities and headache, Manual Muscle Testing Grading System (MMT), Criteria for Sweating Categorization, and 36-Item Short Form Health Survey (SF-36) to evaluate the clinical effects of the treatment.
ResultsIn Case 1, headache improved from peak NRS 9 and average NRS 7 on admission day to both NRS 3 on discharge. The SF-36 score was also increased, suggesting that the quality of life was improved. In Case 2, numbness in the extremities improved from NRS 8 on the day before admission to NRS 2 on discharge, and general condition also improved.
참고문헌1. Zhu N, Zhang D, Wang W, Li X, Yang B, & Song J, et al. (2020). A Novel Coronavirus from Patients with Pneumonia in China. N Engl J Med;382(8):727-33.
http://doi.org/10.1056/NEJMoa2001017
2. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard [Internet]. Geneva (Switzerland): WHO;2022. [cited 2022 Mar 1]. Available from: https://covid19.who.int/table
3. Korea Disease Control and Prevention Agency. COVID-19 [Internet]. Sejong: Ministry of Health and Welfare;2022. [cited 2022 Mar 1]. Available from: http://ncov.mohw.go.kr/
4. Choi WS. (2021). Comprehensive Understanding and Field Application of COVID-19 Vaccine. Korean J Med;96(3):155-9.
http://doi.org/10.3904/kjm.2021.96.3.155
5. Korea Disease Control and Prevention Agency. COVID-19 vaccines [Internet]. Cheongju: Korea Disease Control and Prevention Agency;2022. [cited 2022 Feb 24]. Available from: https://ncv.kdca.go.kr/
6. World Health Organization (WHO). Regional Office for the Western Pacific. Immunization safety surveillance. Guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization. Manila, 1999 [Internet]. Geneva (Switzerland): WHO;2021. [cited 2021 May 7]. Available from: https://apps.who.int/iris/bitstream/handle/10665/208312/9290611820_eng.pdf?sequence=1&isAllowed=y
7. 전국한의과대학폐계내과협의회. 코로나바이러스감염증-19 한의지료 지침. 제2.1판(2020). p. 1-13.
8. 사단법인대한한의사협회. 코로나바이러스감염증-19 한의진료 권고안. 제2판. (2020). p. 1-52.
9. Song JH, & Park SY. (2021). A Case of Recurrent Herpes Zoster after Coronavirus. J Korean Med Ophthalmol Otolaryngol Dermatol;34(4):181-97.
https://doi.org/10.6114/jkood.2021.34.4.181
10. Hölzle E, Hund M, Lommel K, & Melnik B. (2010). Recommendations for tap water iontophoresis. JDDG - J Ger Soc Dermatology;8(5):379-83.
http://doi.org/10.1111/j.1610-0387.2009.07250.x
11. Lee BY, Lee HJ, Kim JW, Choi HY, Kim YJ, & Park JM, et al. (2016). The Efficacy of Shihogayonggolmoryo-tang in Combating Excessive Sweating in Heart Disease Syndrome, Called 心病 in Korean Medicine. J Int Korean Med;37(4):601-8.
https://doi.org/10.22246/jikm.2016.37.4.601
12. Ware JE, & Gandek B. (1998). Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol;51(11):903-12.
https://doi.org/10.1016/S0895-4356(98)00081-X
13. Nam BH, & Lee SW. (2003). Testing the validity of the Korean SF-36 Health Survey. J of the Korean Society of Health Statistics;28(2):3-24.
14. Lee YJ, & Sohn SS. (2014). The Difference of Quality of Life on Blood Stasis Using SF-36. J Korean Obstet Gynecol;27(4):15-24.
15. Korea Centers for Disease Control and Prevention. (2020). Guidelines for management on surveillance of adverse events following immunization. Cheongju (Korea). Korea Centers for Disease Control and Prevention.
16. Jung EH. (2021). Coronavirus disease 2019 vaccines and relevant adverse reactions. Allergy Asthma Respir Dis;9(3):124-135.
http://doi.org/10.4168/aard.2021.9.3.124
17. Ahn SH, & Lee SH. (2021). Updates on Coronavirus Disease 19 Vaccines and Its Clinical Application. Korean J Fam Pract;11(4):236-246.
https://doi.org/10.21215/kjfp.2021.11.4.236
18. Kang SW, Hong SE, Park JW, Kwon SW, Yoon SH, & Kim KI, et al. (2021). Safety of Korean Medicine Treatment in Patients Vaccinated with the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19/AZD1222): A Case Series. J Int Korean Med;42(4):590-604.
https://doi.org/10.22246/jikm.2021.42.4.590
19. Han JH, Kim DG, & Lee JY. (2014). A Case Report of Extensive Limb Swelling in Newborn After Vaccination: Unusual Thigh Swelling After Hepatitis B vaccination. J Int Korean Med;28(1):52-60.
https://doi.org/10.7778/jpkm.2014.28.1.052
20. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, & Lockhart S, et al. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med;383(27):2603-15.
http://doi.org/10.1056/NEJMoa2034577
21. Göbel CH, Heinze A, Karstedt S, Morscheck M, Tashiro L, & Cirkel A, et al. (2021). Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun;3(3):1-10.
https://doi.org/10.1093/braincomms/fcab169
22. 박인상 . 우천경험요결. 1판. 경기도 고양시. 소나무;(2016). p. 82
23. 이광재 . 사상체질과 임상편람 제2권. 2판. 서울. 한미의학;(2010). p. 210-216.
24. 류두저우 . 유도주 상한론강의 1. 1판. 경기도 파주시. 물고기숲;(2014). p. 109-113.
25. Dalpke A, & Helm M. (2012). RNA mediated toll-like receptor stimulation in health and disease. RNA Biology;9(6):828-842.
https://doi.org/10.4161/rna.20206
26. Kim TG, Park SM, Kang H, Shim BS, Kim SH, & Choi SH, et al. (2008). Effect of Baekhasuoyijung-Tang on Mouse T Cell Cytokines. Korean J Oriental Physiology & Pathology;22(4):754-61.
27. Filshie Jacqueline, White Adrian, Cummings Mike. Medical Acupuncture: A Western Scientific Approach. 2nd edition. Seoul. HANMI Medical Publishing Co;(2019). p. 40
|
|